In pts who have HF w either reduced or preserved EF an SGLT2 inhibitor is recommended for glycemic mgmt and prevention of HF hospitalizations A

In pts who have HF (w/ either reduced or preserved EF), an SGLT2 inhibitor is recommended for glycemic mgmt and prevention of HF hospitalizations. [A]